Active ingredientLevobunolol HClCat. No. P-L044-001CAS 27912-14-7Family · Pharmaceutical analytical standards
Levobunolol
A non-selective beta blocker in eye drops, approved in the United States in 1985 to lower eye pressure in open-angle glaucoma and ocular hypertension: it reduces the production of aqueous humour in the ciliary body. This family brings together the active ingredient, nitrosamines and other impurities.
Did you know?It is the levorotatory (L) form of bunolol and is more than 60 times as active as the D form; the suffix -olol immediately marks it as a beta blocker.
Go to the active ingredient →Active ingredientLevobunolol HClCat. No. P-L044-001CAS 27912-14-7
NitrosamineN-Nitroso LevobunololCat. No. P-L044-002
Impurity(R)-Bunolol HClCat. No. P-L044-003CAS 27867-05-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.